Oxycodone Depot Orion
Package leaflet: Information for the patient |
|
Oxycodone Depot Orion 5 mg prolonged-release tablets |
Oxycodone Depot Orion 10 mg prolonged-release tablets Oxycodone Depot Orion 15 mg prolonged-release tablets |
Oxycodone Depot Orion 20 mg prolonged-release tablets Oxycodone Depot Orion 30 mg prolonged-release tablets |
Oxycodone Depot Orion 40 mg prolonged-release tablets Oxycodone Depot Orion 60 mg prolonged-release tablets |
Oxycodone Depot Orion 80 mg prolonged-release tablets |
|
Oxycodone hydrochloride |
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
|
What is in this leaflet: 1. What Oxycodone Depot Orion is and what it is used for 2. What you need to know before you take Oxycodone Depot Orion 3. How to take Oxycodone Depot Orion 4. Possible side effects 5. How to store Oxycodone Depot Orion Content of the pack and other information |
1. What Oxycodone Depot Orion is and what it is used for |
Oxycodone Depot Orion (oxycodone hydrochloride) is a centrally acting, strong painkiller from the group of opioids. Oxycodone Depot Orion is used to treat severe pain, which can be adequately managed only with opioid analgesics. Oxycodone Depot Orion is indicated in adults and adolescents aged 12 years and older. |
Method of administration |
Swallow the prolonged-release tablet whole with a sufficient amount of liquid (½ glass of water) with or without food in the morning and in the evening following a fixed schedule (e.g. at 8 a.m. and 8 p.m.). The tablets must be swallowed whole, not chewed, divided or crushed as this leads to rapid oxycodone release due to the damage of the prolonged release properties. The administration of chewed, divided or crushed prolonged-release tablets leads to a rapid release and absorption of a potentially fatal dose of oxycodone (see section “If you take more Oxycodone Depot Orion than you should”). The prolonged-release tablets may be taken with or independent of meals with a sufficient amount of liquid. Oxycodone Depot Orion should not be taken with alcoholic beverages. Opening instructions: This medicinal product is in childproof packaging. The prolonged-release tablets cannot be pressed out of the blister. Please follow the opening instruction. Pull off a single dose by tearing along the perforated line on the blister. An unsealed area is exposed/can be reached by this; this area is at the point where the perforated lines intersect with each other. At the unsealed flap, peel away the cover foil from the bottom foil. Further determination of the daily dose, the division into the single doses and any dose adjustments during the further course of therapy are performed by the treating physician and depend on the previous dosage. Some patients who receive Oxycodone Depot Orion according to a fixed schedule need rapidly acting painkillers as rescue medication to control breakthrough pain. Oxycodone Depot Orion is not intended for the treatment of breakthrough pain. The treatment needs to be controlled regularly with regard to pain relief and other effects in order to achieve the best pain therapy possible as well as to be able to treat any occurring side effects in good time and to decide whether treatment should be continued. |
If you take more Oxycodone Depot Orion than you should |
If you have taken more Oxycodone Depot Orion as prescribed you should inform your doctor or your local poison control center immediately. The following symptoms may occur: constricted pupils (miosis), depressed breathing (respiratory depression), drowsiness, skeletal muscle flaccidity and drop in blood pressure. In severe cases circulatory collapse, mental and motor inactivity (stupor), unconsciousness (coma) slowing of the heart rate and accumulation of water in the lungs (non-cardiogenic lung oedema) may occur; abuse of high doses of strong opioids such as oxycodone can be fatal. In no case you should expose yourself to situations requiring elevated concentration e.g. driving a car. |
If you forget to take Oxycodone Depot Orion |
If you use a smaller dose of Oxycodone Depot Orion than directed or you miss the intake of a dose, pain relief will consequently be insufficient or cease altogether. You can make up for a forgotten dose if the next regular intake is not due for at least another 8 hours. You can then continue to take this medicine as directed. You should also take this medicine if the time to the regular next intake is shorter, but postpone the next intake by 8 hours. In principle, you should not take Oxycodone Depot Orion more than once every 8 hours. Do not take a double dose to make up for a forgotten dose. |
If you stop taking Oxycodone Depot Orion |
Do not stop treatment without informing your doctor. When a patient no longer requires therapy with Oxycodone Depot Orion, it may be advisable to taper the dose gradually to prevent symptoms of withdrawal. If you have any further questions on the use of this medicine, ask your doctor or pharmacist. |
4. Possible side effects |
Like all medicines, this medicine can cause side effects, although not everybody gets them. |
Significant side effects or signs to consider and measures to be taken when these side effects or signs occur: If you experience any of the following side effects, stop taking Oxycodone Depot Orion and contact your doctor immediately. Depressed breathing is the most significant risk induced by opioids and is most likely to occur in elderly or debilitated patients. As a consequence, in predisposed patients opioids can cause severe drops in blood pressure. Apart from this oxycodone can cause constricted pupils, bronchial spasms and spasms in smooth muscles and suppress the cough reflex. |
Other possible side effects Very common (may affect more than 1 in 10 people): Sedation (tiredness to drowsiness); dizziness; headache; constipation; nausea; vomiting; itching. Common (may affect up to 1 in 10 people): Several psychological side effects such as changes in mood
(e.g. anxiety, depression); changes in activity (mostly sedation,
sometimes accompanied by lethargy, occasionally increase with
nervousness and sleep disorders) and changes in performance
(thought process disorder, confusion, isolated cases of speech
disorders), lack of strengths (asthenic conditions). Uncommon (may affect up to 1 in 100 people): A
condition which causes abnormal production of a hormone reducing
urination (syndrome of inappropriate antidiuretic hormone
secretion), Rare (may affect up to 1 in 1,000 people): Lymph node disease (lymphadenopathy), Frequency not known (frequency cannot be estimated from the available data) anaphylactic
reaction, Opioid withdrawal syndrome As oxycodone hydrochloride has the potential to cause a drug addiction, there is a possibility to develop an opioid abstinence or withdrawal syndrome is characterized by some or all of the following: restlessness, watery eyes (lacrimation), rhinorrhoea, yawning, perspiration, chills, muscle pain, dilation of the pupil and irregular heartbeat (palpitations). Other symptoms also may develop including: irritability, anxiety, backache, joint pain, weakness, abdominal cramps, insomnia, nausea, anorexia, vomiting, diarrhea, or increased blood pressure, respiratory rate or heart rate. Counteractive measuresIf you observe any of the above listed side effects your doctor usually will take appropriate measures. The side effect constipation may be prevented by fiber enriched diet and increased drinking. Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine. |
5. How to store Oxycodone Depot Orion |
Keep this medicine out of the sight and reach of children. |
Do not use this medicine after the expiry date which is stated on the blister and the carton after “EXP”. The expiry date refers to the last day of that month. Oxycodone Depot Orion 5 mg Do not store above 25°C Oxycodone Depot Orion 10 mg Do not store above 30°C Oxycodone Depot Orion 15 mg / 20 mg / 30 mg / 40 mg / 60 mg / 80 mg This medicinal product does not require any special storage conditions |
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment. |
6. Content of the pack and other information |
What Oxycodone Depot Orion contains |
The active substance is oxycodone hydrochloride. 5 mg: The other ingredients are: Tablet coating: Hypromellose, talc, macrogol 400, titanium dioxide (E171), brilliant blue FCF (E133). 10 mg: The other ingredients are: Lactose monohydrate, Ammonio Methacrylate Copolymer, Type B, Povidone (K29/32), Talc, Triacetin, Stearyl alcohol, Magnesium stearate, Tablet coating: Hypromellose, Talc, Macrogol 400, Titanium dioxide (E171) 15 mg: The other ingredients are: Tablet core: Lactose monohydrate, Ammonio Methacrylate Copolymer, Type B, Povidone (K29/32), Talc, Triacetin, Stearyl alcohol, Magnesium stearate Tablet coating: Hypromellose, Talc, Macrogol 400, Titanium dioxide (E171), Iron oxide black (E172) 20 mg: Each prolonged-release tablet contains 20 mg oxycodone hydrochloride corresponding to 17.9 mg oxycodone. The other ingredients are: Tablet core: Lactose monohydrate, Ammonio Methacrylate Copolymer, Type B, Povidone (K29/32), Talc, Triacetin, Stearyl alcohol, Magnesium stearate, Tablet coating: Hypromellose, Talc, Macrogol 400, Titanium dioxide (E171), Iron oxide red (E172), 30 mg: Each prolonged-release tablet contains 30 mg oxycodone hydrochloride corresponding to 26.9 mg oxycodone. The other ingredients are: Tablet core: Lactose monohydrate, Ammonio Methacrylate Copolymer, Type B, Povidone (K29/32), Talc, Triacetin, Stearyl alcohol, Magnesium stearate Tablet coating: Hypromellose, Talc, Macrogol 400, Titanium dioxide (E171), Iron oxide brown (E172), Iron oxide black (E172) 40 mg: The other ingredients are: Lactose monohydrate, Ammonio Methacrylate Copolymer, Type B, Povidone (K29/32), Talc, Triacetin, Stearyl alcohol, Magnesium stearate Tablet coating: Hypromellose, Talc, Macrogol 400, Titanium dioxide (E171), Iron oxide red (E172), Iron oxide yellow (E172) 60 mg: The other ingredients are: Tablet core: Lactose monohydrate, Ammonio Methacrylate Copolymer, Type B, Povidone (K29/32), Talc, Triacetin, Stearyl alcohol, Magnesium stearate Tablet coating: Hypromellose, Talc, Macrogol 400, Titanium dioxide (E171), Iron oxide red (E172), Erythrosine (E127) 80 mg: The other ingredients are: Tablet core: Lactose monohydrate, Ammonio Methacrylate Copolymer, Type B, Povidone (K29/32), Talc, Triacetin, Stearyl alcohol, Magnesium stearate Tablet coating: Hypromellose, Talc, Macrogol 400, Titanium dioxide (E171), Indigo carmine (E132), Iron oxide yellow (E172) |
What Oxycodone Depot Orion looks like and contents of the pack |
Oxycodone Depot
Orion 5 mg prolonged-release tablets: Oxycodone Depot
Orion 10 mg
prolonged-release tablets: Oxycodone Depot
Orion 15 mg
prolonged-release tablets: Oxycodone
Depot Orion 20 mg prolonged-release
tablets: Oxycodone Depot
Orion 30 mg prolonged-release
tablets: Oxycodone Depot
Orion 40 mg
prolonged-release tablets: Oxycodone Depot
Orion 60 mg
prolonged-release tablets: Oxycodone Depot
Orion 80 mg
prolonged-release tablets: |
Oxycodone Depot Orion is available in child-resistant perforated unit dose blisters with 10x1, 14x1, 20x1, 25x1, 28x1, 30x1, 40x1, 50x1, 56x1, 60x1, 98x1 and 100x1 prolonged-release tablets. Not all pack sizes may be marketed. |
|
Marketing Authorisation Holder |
To be completed nationally |
Manufacturer |
To be completed nationally |
This medicinal product is authorised in the Member States of the EEA under the following names: |
DK: Orionox 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 60 mg, 80 mg depottabletter FI: Oxycodone Orion 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 60 mg, 80 mg depottabletit NO: Orionox SE: Oxycodone Depot Orion 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 60 mg, 80 mg depottabletter |
This leaflet was last revised in |
2016-10-27
4